GB9414157D0 - Medical use - Google Patents
Medical useInfo
- Publication number
- GB9414157D0 GB9414157D0 GB9414157A GB9414157A GB9414157D0 GB 9414157 D0 GB9414157 D0 GB 9414157D0 GB 9414157 A GB9414157 A GB 9414157A GB 9414157 A GB9414157 A GB 9414157A GB 9414157 D0 GB9414157 D0 GB 9414157D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- medical use
- medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9414157A GB9414157D0 (en) | 1994-07-13 | 1994-07-13 | Medical use |
PCT/EP1995/002693 WO1996002240A2 (en) | 1994-07-13 | 1995-07-07 | Use of inhibitors of human s-cd23 |
EP95943503A EP0769939A1 (en) | 1994-07-13 | 1995-07-07 | Use of inhibitors of human s-cd23 |
JP8504670A JPH10502656A (en) | 1994-07-13 | 1995-07-07 | Use of inhibitors of human S-CD23 |
US10/038,331 US20020082200A1 (en) | 1994-07-13 | 2002-01-03 | Use of inhibitors of human S-CD23 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9414157A GB9414157D0 (en) | 1994-07-13 | 1994-07-13 | Medical use |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9414157D0 true GB9414157D0 (en) | 1994-08-31 |
Family
ID=10758281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9414157A Pending GB9414157D0 (en) | 1994-07-13 | 1994-07-13 | Medical use |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0769939A1 (en) |
JP (1) | JPH10502656A (en) |
GB (1) | GB9414157D0 (en) |
WO (1) | WO1996002240A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9601042D0 (en) * | 1996-01-17 | 1996-03-20 | Smithkline Beecham Plc | Medical use |
US6548084B2 (en) | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
GB9609794D0 (en) * | 1996-05-10 | 1996-07-17 | Smithkline Beecham Plc | Novel compounds |
GB9609795D0 (en) * | 1996-05-10 | 1996-07-17 | Smithkline Beecham Plc | Novel compounds |
GB9706255D0 (en) * | 1997-03-26 | 1997-05-14 | Smithkline Beecham Plc | Novel compounds |
GB9813451D0 (en) * | 1998-06-22 | 1998-08-19 | Smithkline Beecham Plc | Novel compounds |
EP1101492A4 (en) * | 1998-07-17 | 2002-09-25 | Daiichi Fine Chem Co Ltd | Novel remedies for allergic diseases |
AU4653299A (en) * | 1998-07-17 | 2000-02-07 | Daiichi Fine Chemical Co., Ltd. | Therapeutic agents for allergic diseases |
GB9929527D0 (en) * | 1999-12-14 | 2000-02-09 | Smithkline Beecham Plc | Novel compounds |
GB9930754D0 (en) * | 1999-12-29 | 2000-02-16 | Smithkline Beecham Plc | Novel compounds |
AU2001233965A1 (en) * | 2000-02-24 | 2001-09-03 | Smithkline Beecham Plc | Novel cd23 inhibitors |
EP1142910A1 (en) * | 2000-04-07 | 2001-10-10 | Jürgen Prof. Dr. Frey | Inhibitors for the formation of soluble human CD23 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8827305D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
GB8827308D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
WO1990011287A1 (en) * | 1989-03-21 | 1990-10-04 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | Matrix metalloproteinase inhibitor peptides |
GB9001625D0 (en) * | 1990-01-24 | 1990-03-21 | Ciba Geigy Ag | A pharmaceutical preparation for maturation of prothymocytes |
AU655943B2 (en) * | 1990-09-21 | 1995-01-19 | Salk Institute For Biological Studies, The | Functional antagonism between proto-oncoprotein c-jun and hormone receptors |
WO1992016517A1 (en) * | 1991-03-22 | 1992-10-01 | Xenova Limited | Pharmaceutical xanthone derivatives |
KR930002833A (en) * | 1991-07-08 | 1993-02-23 | 강석재 | Device for checking break of electric circuit |
WO1993018173A2 (en) * | 1992-03-11 | 1993-09-16 | Xenova Limited | Cd4 binding agents and inhibitors of collagenase and protein kinase c |
EP0634998B1 (en) * | 1992-04-07 | 1997-03-19 | British Biotech Pharmaceuticals Limited | Hydroxamic acid based collagenase and cytokine inhibitors |
GB9223904D0 (en) * | 1992-11-13 | 1993-01-06 | British Bio Technology | Inhibition of cytokine production |
NZ262447A (en) * | 1993-03-16 | 1996-07-26 | British Biotech Pharm | Hydroxamic acid derivatives and their use as pharmaceutical agents |
GB9307956D0 (en) * | 1993-04-17 | 1993-06-02 | Walls Alan J | Hydroxamic acid derivatives |
GB9320660D0 (en) * | 1993-10-07 | 1993-11-24 | British Bio Technology | Inhibition of cytokine production |
GB9323165D0 (en) * | 1993-11-10 | 1994-01-05 | Chiros Ltd | Compounds |
PL179997B1 (en) * | 1994-01-20 | 2000-11-30 | British Biotech Pharm | Inhibitors of metalloproteinases |
GB9401129D0 (en) * | 1994-01-21 | 1994-03-16 | British Bio Technology | Hydroxamic acid derivatives as metalloproteinase inhibitors |
CA2181709A1 (en) * | 1994-01-22 | 1995-07-27 | Raymond Paul Beckett | Hydroxamic acid derivatives as metalloproteinase inhibitors |
-
1994
- 1994-07-13 GB GB9414157A patent/GB9414157D0/en active Pending
-
1995
- 1995-07-07 WO PCT/EP1995/002693 patent/WO1996002240A2/en not_active Application Discontinuation
- 1995-07-07 JP JP8504670A patent/JPH10502656A/en not_active Ceased
- 1995-07-07 EP EP95943503A patent/EP0769939A1/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
WO1996002240A2 (en) | 1996-02-01 |
WO1996002240A3 (en) | 1997-02-13 |
EP0769939A1 (en) | 1997-05-02 |
JPH10502656A (en) | 1998-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2285582B (en) | Medical clip | |
EP0699419A3 (en) | Osteosynthetic fixateur | |
EP0785806A4 (en) | Single use syringe | |
GB9425493D0 (en) | Modified cannula | |
GB9414157D0 (en) | Medical use | |
HUP9901448A3 (en) | Novel medical use | |
ZA953237B (en) | Medical treatment | |
EP0797592A4 (en) | Human stanniocalcin-alpha | |
ZA947865B (en) | Human glactokinase | |
GB9617550D0 (en) | Medical ice-pack | |
GB9601042D0 (en) | Medical use | |
GB2290706B (en) | Medical device | |
EP0795006A4 (en) | HUMAN MutT2 | |
GB2310804B (en) | Modified cannula | |
GB9606686D0 (en) | Medical use | |
GB9626920D0 (en) | Medical use | |
GB9413025D0 (en) | Patient support | |
GB9418077D0 (en) | Medical aid | |
GB9405084D0 (en) | Medical devices | |
HU9502355D0 (en) | Human interleukin-6-inhibitor | |
ZA949714B (en) | Human MutT2 | |
GB9416297D0 (en) | Disposable scoopsack | |
GB9425164D0 (en) | Medical treatment | |
GB9425773D0 (en) | Medical treatment | |
GB9403306D0 (en) | Medical treatment |